Department of Rheumatology, Päijät-Häme Central Hospital, Lahti, Finland.
Unit of Physiatry and Rehabilitation Medicine, Päijät-Häme Central Hospital, Lahti, Finland.
Eur J Intern Med. 2024 Mar;121:56-62. doi: 10.1016/j.ejim.2023.10.009. Epub 2023 Oct 17.
Both hyperuricaemia and chronic kidney disease are known mortality risk factors. This study examined the modifying effect of renal function on hyperuricaemia-associated mortality risk, which is an issue that has not been studied before.
Data on levels of serum uric acid (SUA), creatinine, cystatin C and other variables of persons aged 52-76 years were collected. Persons with SUA >410 μmol/L (75th percentile) were classified as clearly hyperuricaemic and persons with eGFR of ≤67 ml/min (25th percentile) as having reduced kidney function.
Reduced kidney function was associated with higher mortality in both SUA groups. When compared to individuals with SUA ≤410 μmol/L and eGFR >67 ml/min the hazard ratio (HR) for all-cause mortality was 1.53 (95 % CI: 1.26-1.84) in clearly hyperuricaemic persons with reduced kidney function, 1.26 (95 % CI: 1.02-1.55) in clearly hyperuricaemic persons with eGFR of >67 ml/min and 1.15 (95 % CI: 0.96-1.39) in persons with SUA ≤410 μmol/L and reduced kidney function. The HR for hyperuricaemia-related premature death was lowest in individuals with reduced eGFR, and it rose strikingly as the eGFR increased above 90 ml/min.
Reduced kidney function is a risk factor for mortality both in individuals with normal and elevated SUA. The hyperuricaemia-associated mortality risk is remarkably higher in individuals with normal kidney function than in individuals with reduced kidney function. Presumably overproduction of uric acid (metabolic hyperuricaemia) is a separate and more deleterious entity than hyperuricaemia resulting from reduced renal excretion of uric acid (renal hyperuricaemia).
高尿酸血症和慢性肾脏病都是已知的死亡风险因素。本研究探讨了肾功能对高尿酸血症相关死亡风险的调节作用,这是一个以前尚未研究过的问题。
收集了 52-76 岁人群的血清尿酸(SUA)、肌酐、胱抑素 C 及其他变量的数据。将 SUA>410μmol/L(第 75 百分位数)的人群归类为明确高尿酸血症,将 eGFR≤67ml/min(第 25 百分位数)的人群归类为肾功能降低。
肾功能降低与两个 SUA 组的死亡率升高相关。与 SUA≤410μmol/L 和 eGFR>67ml/min 的个体相比,肾功能降低的明确高尿酸血症患者的全因死亡率的危险比(HR)为 1.53(95%CI:1.26-1.84),eGFR>67ml/min 的明确高尿酸血症患者的 HR 为 1.26(95%CI:1.02-1.55),SUA≤410μmol/L 且肾功能降低的患者的 HR 为 1.15(95%CI:0.96-1.39)。在 eGFR 降低的个体中,高尿酸血症相关的过早死亡的 HR 最低,而当 eGFR 升高到 90ml/min 以上时,HR 显著升高。
肾功能降低是正常和升高的 SUA 个体死亡的危险因素。在肾功能正常的个体中,高尿酸血症相关的死亡风险明显高于肾功能降低的个体。推测尿酸的过度产生(代谢性高尿酸血症)是一种独立的、更具危害性的实体,而不是尿酸排泄减少导致的高尿酸血症(肾性高尿酸血症)。